Damora Therapeutics, Inc. (DMRA)

Damora Therapeutics, Inc. (DMRA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.2B; returns 1 day -2.9%, 1 week +14.4%.

Damora Therapeutics (DMRA) is a clinical-stage biotechnology company focused on the development of small molecule therapeutics for fibrosis, cancer, and inflammatory diseases. As of March 2026, the company operates without traditional product revenue, sustained by capital markets and strategic partnerships.

Groups DMRA belongs to

• Clinical Stage Biotech
• Recent IPOs
• Biotechnology
• Clinical Stage Biopharma
• Fibrosis
• Liver Disease
• Oncology
• Biopharmaceutical
• Chronic Inflammatory Diseases
• Healthcare

DMRA financial model: income statement, cash flow and balance sheet